iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Mutual Advisors LLC

Mutual Advisors LLC trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,600 shares of the financial services provider’s stock after selling 108 shares during the quarter. Mutual Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,359,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Jane Street Group LLC purchased a new stake in shares of iShares Biotechnology ETF during the first quarter worth approximately $14,386,000. Cetera Investment Advisers raised its position in iShares Biotechnology ETF by 689.4% during the 1st quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after buying an additional 79,541 shares during the last quarter. State of Michigan Retirement System raised its position in iShares Biotechnology ETF by 150.0% during the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after buying an additional 75,000 shares during the last quarter. Aristides Capital LLC acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter worth $9,180,000. Finally, Sanctuary Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF in the second quarter valued at about $8,118,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $142.78 on Friday. iShares Biotechnology ETF has a 52-week low of $113.56 and a 52-week high of $150.57. The firm has a 50-day moving average price of $145.02 and a 200 day moving average price of $140.37.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.